BridgeMD
New treatment option for Patients With Schizophrenia-like Disorders
Official title Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders
ClinicalTrials.gov ID: NCT05349513
What this study is testing
- What it's testing
- The study use a new ecological questionnaire called ESSME developed by a care team in order to evaluate ecological environment of patients with schizophrenia-like disorders. Indeed, evaluation in an ecological environment would make it possible to be as close as possible to the concerns of theses patients, which could improve the care of this population, by making it possible to set with the patient objectives anchored in their daily life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- man or woman aged 18 to 65 inclusive;
- diagnosis of schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders version number 5...
- patient receiving care in a Center for Rehabilitation and Intersectoral Therapeutic Activities (CREATIV);
- person who consented to the study;
- affiliate or beneficiary of a social security scheme.
You likely can't join if
- patient aged under 18 or over 65;
- pregnant or breastfeeding women;
- person unable or unwilling to receive a home visit;
- person not consenting to the study;
- presence of a diagnosis of an associated neurodevelopmental disorder;
- presence of a diagnosis of dementia or associated neurodegenerative process;
See the full eligibility criteria
- man or woman aged 18 to 65 inclusive;
- diagnosis of schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders version number 5 (DSM-V) criteria;
- patient receiving care in a Center for Rehabilitation and Intersectoral Therapeutic Activities (CREATIV);
- person who consented to the study;
- affiliate or beneficiary of a social security scheme.
- patient aged under 18 or over 65;
- pregnant or breastfeeding women;
- person unable or unwilling to receive a home visit;
- person not consenting to the study;
- presence of a diagnosis of an associated neurodevelopmental disorder;
- presence of a diagnosis of dementia or associated neurodegenerative process;
- person with a level of French language insufficient to understand the items.
The study team makes the final eligibility decision.
Where it's taking place
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.